Article: JAPAN'S BANYU GEARS UP TO MARKET HAIR LOSS DRUG PROPECIA.

TOKYO, Oct 12 Asia Pulse - Banyu Pharmaceutical Co. (TSE:4515) has obtained government approval to import the prescription hair loss medication Propecia and expects to begin sales as early as the second half of November.

Developed by Banyu's parent Merck & Co., Propecia is an oral medicine that has proven effective in treating male pattern baldness on the top and middle front of the head. Merck is already selling Propecia in more than 60 countries.

Banyu will sell Propecia in Japan as a ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!